TIMER2, which offers many existing algorithms (Li et al., 2020; Aran et al., 2017; Newman et al., 2015; Racle et al., 2017; Li et al., 2017) for estimating tumor-infiltrating immune cell populations, showed a remarkable correlation between LEPROT expression and CD4+, CD8+, and regulatory T cells (Figure 2B). This evidence concerns the gene CD8A and neoplasm.